Transitional Cell Cancer of the Renal Pelvis and Ureter Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Transitional Cell Cancer of Renal Pelvis and Ureter / Transitional Cell Tumor / Transitional cell carcinoma of upper urinary tract (disorder) / Transitional cell cancer of the renal pelvis and ureter NOS / Renal pelvis and ureter transitional cell cancer NOS / Renal pelvis and ureteric cancer NOS transitional cell / Renal pelvis and ureteral cancer transitional cell NOS / Renal pelvis and ureteric cancer transitional cell NOS

IndicationStatusPhase
DBCOND0028512 (Transitional Cell Cancer of the Renal Pelvis and Ureter)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005644Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionTreatment
NCT00310011Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumTreatment
NCT00045630S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumTreatment
NCT00028860Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract CancerTreatment